Corvus Pharmaceuticals, Inc.
live · Yahoo FinanceModerate buying: $2.6M bought (counted up to $5.0M); a CEO among the buyers. Holding it back: largest buyer: MILLER RICHARD A MD (CEO), 48% of the dollars.
Score, not a recommendation.
Price and insider purchases
Live chart from Yahoo Finance, loaded through this server; our daily closes when it is unavailable.
Loading price history…
How the score adds up
How each input is counted →| Input | Strength | Points |
|---|---|---|
| $2.6M bought (counted up to $5.0M)The dollars the insiders bought, a purchase reported jointly counted once, counted from $131. Each tenfold adds 12.4 points, up to $5.0M; more adds nothing. The bar is empty at $10.0K and full at $5.0M. | 90% | +53 |
| 4 distinct insidersHow many different insiders bought. Each extra insider adds less than the one before (the points follow the log of the count: 4.3 per doubling). The bar is full at 10 insiders. | 60% | +9 |
| A CEO among the buyersWhether the chief executive is among the buyers: 10.6 points when yes. | 100% | +11 |
| Stock 70% below its 1-year high (counted up to 30%)How far the stock had fallen from its highest close of the past year, at the close before the buying. Every 10% of fall adds 1.9 points. A fall beyond 30% adds nothing more. The bar is full at a 30% fall. | 100% | +5 |
| 25 days from first to last purchaseDays between the first and the last purchase. Each day takes off 0.11 points: buying close together keeps more. The bar is empty at 60 days. | 58% | -3 |
| Routine or plan purchases: 0% of the dollars | 100% | +0 |
| Largest buyer: MILLER RICHARD A MD (CEO), 48% of the dollars | 69% | -6 |
| Match scoreA score from 0 to 100 worked out from the dollars bought, the number of insiders, whether a CEO bought, how far the stock had fallen, how spread out the purchases were and how much came from one buyer. Its weights were calibrated on past clusters. It is the default ranking of the lists and it decides which clusters get the AI review. It describes the buying; it is not a forecast. | 69 | |
Why are they buying?
No explanation has been generated for this cluster. The filings in the table below are the primary evidence.
| Date | InsiderAn officer or director of a company, or an owner of more than 10% of its shares. The law requires them to report their trades in the company's stock to the SEC. | Role | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2019-06-27 → 2019-07-01 | ORBIMED ADVISORS LLC 7 purchases with a 63-day result · median +5.5% | Director | 657,344 | $3.72 avg | $2.4M | |
| 2019-06-27 | ORBIMED ADVISORS LLC | 32,923 | $3.34 | $110.0K | SEC filing for ORBIMED ADVISORS LLC (opens in a new tab) | |
| 2019-06-28 | ORBIMED ADVISORS LLC | 565,178 | $3.72 | $2.1M | SEC filing for ORBIMED ADVISORS LLC (opens in a new tab) | |
| 2019-07-01 | ORBIMED ADVISORS LLC | 59,243 | $3.91 | $231.6K | SEC filing for ORBIMED ADVISORS LLC (opens in a new tab) | |
| 2019-06-27 → 2019-07-01 | Thompson Peter A. 7 purchases with a 63-day result · median +5.5% | Director | 657,344 | $3.72 avg | $2.4M | |
| 2019-06-27 | Thompson Peter A. | 32,923 | $3.34 | $110.0K | SEC filing for Thompson Peter A. (opens in a new tab) | |
| 2019-06-28 | Thompson Peter A. | 565,178 | $3.72 | $2.1M | SEC filing for Thompson Peter A. (opens in a new tab) | |
| 2019-07-01 | Thompson Peter A. | 59,243 | $3.91 | $231.6K | SEC filing for Thompson Peter A. (opens in a new tab) | |
| 2019-06-07 → 2019-06-14 | MILLER RICHARD A MD 22 purchases with a 63-day result · median -4.7% | CEO | 27,212 | $3.45 avg | $93.9K | |
| 2019-06-07 | MILLER RICHARD A MD | 9,212 | $3.37 | $31.0K | SEC filing for MILLER RICHARD A MD (opens in a new tab) | |
| 2019-06-11 | MILLER RICHARD A MD | 6,000 | $3.67 | $22.0K | SEC filing for MILLER RICHARD A MD (opens in a new tab) | |
| 2019-06-13 | MILLER RICHARD A MD | 343 | $3.52 | $1.2K | SEC filing for MILLER RICHARD A MD (opens in a new tab) | |
| 2019-06-14 | MILLER RICHARD A MD | 11,657 | $3.40 | $39.6K | SEC filing for MILLER RICHARD A MD (opens in a new tab) | |
| 2019-06-06 → 2019-06-07 | LEA LEIV 4 purchases with a 63-day result · median -7.0% | CFO | 25,500 | $3.49 avg | $89.0K | |
| 2019-06-06 | LEA LEIV | 15,500 | $3.56 | $55.2K | SEC filing for LEA LEIV (opens in a new tab) | |
| 2019-06-07 | LEA LEIV | 10,000 | $3.38 | $33.8K | SEC filing for LEA LEIV (opens in a new tab) | |
| Total | $5.1M | |||||
Other buying runs at CRVS
A buying runPurchases at one company with no pause longer than the cluster rule allows. A long pause ends the run, so one company can have several. ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmarkThe index a stock's return is compared with: a small-cap index for small companies, a large-cap index otherwise. (IWM for small companies, SPY otherwise), from the first open after the buying run became a cluster. Past results, not a forecast.
After this buying run became a cluster, vs benchmark: 21 days -7.7% (-8.8% raw)63 days –126 days +22.6% (+29.5% raw)
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2022-12-13 → 2022-12-20 | 3 | $86.2K | 51 | -7.1% (0.0% raw) | -12.8% (-13.9% raw) | +156.5% (+160.8% raw) | closed |
| 2021-02-17 | 3 | $9.3M | 60 | -19.4% (-22.3% raw) | -29.7% (-31.1% raw) | -48.4% (-51.6% raw) | closed |
| 2019-08-06 → 2019-08-07 | 3 | $1.0M | 61 | +10.6% (+11.7% raw) | -3.3% (+1.3% raw) | +21.4% (+31.2% raw) | closed |
| 2018-03-12 | 6 | $30.8M | 66 | +7.0% (+3.9% raw) | +11.7% (+16.8% raw) | -14.5% (-6.7% raw) | closed |